None
Quote | Nascent Biotech (OTCMKTS:NBIO)
Last: | $0.09833 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0998 |
Close: | $0.09833 |
High: | $0.0998 |
Low: | $0.09294 |
Volume: | 30,000 |
Last Trade Date Time: | 05/07/2024 03:00:00 am |
News | Nascent Biotech (OTCMKTS:NBIO)
2024-04-16 08:17:56 ET More on Nascent Biotech, Inc. Financial information for Nascent Biotech, Inc. Read the full article on Seeking Alpha For further details see: Nascent Biotech prepares for pivotal Phase II research with fresh manufacturing run
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
Message Board Posts | Nascent Biotech (OTCMKTS:NBIO)
Subject | By | Source | When |
---|---|---|---|
Nothing has changed. I cannot find any | gladeshawk | investorshub | 05/02/2024 3:52:17 PM |
Anyone know what caused the 33% drop today? | JS016 | investorshub | 04/08/2024 2:45:06 PM |
Perhaps successful collaboration with Hypospray could be expanded | Aa5 | investorshub | 03/27/2024 6:23:53 PM |
Rebounded as expected. Now we need some | gladeshawk | investorshub | 03/27/2024 4:49:44 PM |
Several sites/boards have $NBIO as a BUY. | gladeshawk | investorshub | 03/20/2024 6:56:29 PM |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...